IL17A and colitis: We found significantly increased IL-17A+ CD4+ T cells, after DDC+DSS treatment while frequencies of Foxp3+ Treg, and IFNγ+ CD4+ T cells were comparable between DDC treated mice with and without acute DSS colitis (Supplementary Figure S2B).